chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Peripheral swelling, Pharyngeal swelling, Pruritus, Skin burning sensation
Clinical narrative: Arm burning and hot; Arm stinging; itchy; hard arm; felt like my throat might of been a little swollen; Arm was swollen/puffy; Felt terrible; Tired; lethargic; Red arm; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (felt like my throat might of been a little swollen), PERIPHERAL SWELLING (Arm was swollen/puffy), FEELING ABNORMAL (Felt terrible), SKIN BURNING SENSATION (Arm burning and hot) and PAIN (Arm stinging) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PERIPHERAL SWELLING (Arm was swollen/puffy), FEELING ABNORMAL (Felt terrible), LETHARGY (lethargic), ERYTHEMA (Red arm) and FATIGUE (Tired). On 24-Jan-2021, the patient experienced PHARYNGEAL SWELLING (felt like my throat might of been a little swollen). On 30-Jan-2021, the patient experienced SKIN BURNING SENSATION (Arm burning and hot), PAIN (Arm stinging), PRURITUS (itchy) and INDURATION (hard arm). On 23-Jan-2021, FEELING ABNORMAL (Felt terrible) had resolved. On 27-Jan-2021, PHARYNGEAL SWELLING (felt like my throat might of been a little swollen) had resolved. At the time of the report, PERIPHERAL SWELLING (Arm was swollen/puffy), SKIN BURNING SENSATION (Arm burning and hot), PAIN (Arm stinging), LETHARGY (lethargic), ERYTHEMA (Red arm), PRURITUS (itchy), INDURATION (hard arm) and FATIGUE (Tired) outcome was unknown.            Concomitant medications were not provided.  Treatment medications included antihistamines for swelling and itching.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: No specific follow-up information recorded.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Pain in extremity, Vaccination site erythema, Vaccination site inflammation, Vaccination site warmth
Clinical narrative: Developed an itchy rash on her back and HCP diagnosed it as shingles; Warm at the injection site; 3" diameter area that is raised,firm at the injection site; Red at the injection site; Right arm was a little sore; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (Developed an itchy rash on her back and HCP diagnosed it as shingles), PAIN IN EXTREMITY (Right arm was a little sore), VACCINATION SITE WARMTH (Warm at the injection site), VACCINATION SITE INFLAMMATION (3" diameter area that is raised,firm at the injection site) and VACCINATION SITE ERYTHEMA (Red at the injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included Shingles (The caller stated that she was having symptoms of getting shingles prior to the Moderna COVID-19 vaccine.) in January 2021. Previously administered products included for an unreported indication: ZOSTAVAX. Concurrent medical conditions included Drug allergy (Allergic to Propylthiouracil. She also has a lot of drug sensitivity but didnot list them.).    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (Right arm was a little sore). On 26-Jan-2021, the patient experienced HERPES ZOSTER (Developed an itchy rash on her back and HCP diagnosed it as shingles), VACCINATION SITE WARMTH (Warm at the injection site), VACCINATION SITE INFLAMMATION (3" diameter area that is raised,firm at the injection site) and VACCINATION SITE ERYTHEMA (Red at the injection site). At the time of the report, HERPES ZOSTER (Developed an itchy rash on her back and HCP diagnosed it as shingles), PAIN IN EXTREMITY (Right arm was a little sore), VACCINATION SITE WARMTH (Warm at the injection site), VACCINATION SITE INFLAMMATION (3" diameter area that is raised,firm at the injection site) and VACCINATION SITE ERYTHEMA (Red at the injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment details included ibuprofen.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pain, Fatigue, Feeling abnormal, Flushing, Headache
Clinical narrative: really bad reaction; didn't feel like she could move; Feeling strange; Fever; Extreme fatigue; Horrible headache, piercing; Pain in the eyes and nose; Pain in nose; Heart racing; Flushed cheeks; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (Flushed cheeks), VACCINATION COMPLICATION (really bad reaction), HYPOKINESIA (didn't feel like she could move), FEELING ABNORMAL (Feeling strange) and PALPITATIONS (Heart racing) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in March 2020. Concurrent medical conditions included Cholesterol and Hypertension.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced FLUSHING (Flushed cheeks) and PALPITATIONS (Heart racing). On 28-Jan-2021, the patient experienced PYREXIA (Fever), FATIGUE (Extreme fatigue), HEADACHE (Horrible headache, piercing), EYE PAIN (Pain in the eyes and nose) and RHINALGIA (Pain in nose). On an unknown date, the patient experienced VACCINATION COMPLICATION (really bad reaction), HYPOKINESIA (didn't feel like she could move) and FEELING ABNORMAL (Feeling strange). At the time of the report, FLUSHING (Flushed cheeks), PALPITATIONS (Heart racing), PYREXIA (Fever), FATIGUE (Extreme fatigue), HEADACHE (Horrible headache, piercing), EYE PAIN (Pain in the eyes and nose) and RHINALGIA (Pain in nose) had resolved and VACCINATION COMPLICATION (really bad reaction), HYPOKINESIA (didn't feel like she could move) and FEELING ABNORMAL (Feeling strange) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start dates of the events, a causal relationship cannot be excluded.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Hypokinesia, Palpitations, Pyrexia, Rhinalgia, Vaccination complication
Clinical narrative: really bad reaction; didn't feel like she could move; Feeling strange; Fever; Extreme fatigue; Horrible headache, piercing; Pain in the eyes and nose; Pain in nose; Heart racing; Flushed cheeks; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (Flushed cheeks), VACCINATION COMPLICATION (really bad reaction), HYPOKINESIA (didn't feel like she could move), FEELING ABNORMAL (Feeling strange) and PALPITATIONS (Heart racing) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in March 2020. Concurrent medical conditions included Cholesterol and Hypertension.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced FLUSHING (Flushed cheeks) and PALPITATIONS (Heart racing). On 28-Jan-2021, the patient experienced PYREXIA (Fever), FATIGUE (Extreme fatigue), HEADACHE (Horrible headache, piercing), EYE PAIN (Pain in the eyes and nose) and RHINALGIA (Pain in nose). On an unknown date, the patient experienced VACCINATION COMPLICATION (really bad reaction), HYPOKINESIA (didn't feel like she could move) and FEELING ABNORMAL (Feeling strange). At the time of the report, FLUSHING (Flushed cheeks), PALPITATIONS (Heart racing), PYREXIA (Fever), FATIGUE (Extreme fatigue), HEADACHE (Horrible headache, piercing), EYE PAIN (Pain in the eyes and nose) and RHINALGIA (Pain in nose) had resolved and VACCINATION COMPLICATION (really bad reaction), HYPOKINESIA (didn't feel like she could move) and FEELING ABNORMAL (Feeling strange) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start dates of the events, a causal relationship cannot be excluded.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Erythema, Fatigue, Rash, Tenderness
Clinical narrative: Tired; Tenderness; Redness; Fatigue; Pain at injection (left); Rash; Bruise; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CONTUSION (Bruise), TENDERNESS (Tenderness), RASH (Rash), ERYTHEMA (Redness) and FATIGUE (Fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced CONTUSION (Bruise), RASH (Rash), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain at injection (left)). On 28-Jan-2021, the patient experienced TENDERNESS (Tenderness) and ERYTHEMA (Redness). On 30-Jan-2021, the patient experienced FATIGUE (Tired). On 23-Jan-2021, CONTUSION (Bruise), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain at injection (left)) had resolved. On 27-Jan-2021, RASH (Rash) had resolved. On 01-Feb-2021, TENDERNESS (Tenderness) and ERYTHEMA (Redness) had resolved. At the time of the report, FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment details included neosporin ointment, lidocaine and recommended getting vaccine in different arm.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Tired; Tenderness; Redness; Fatigue; Pain at injection (left); Rash; Bruise; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CONTUSION (Bruise), TENDERNESS (Tenderness), RASH (Rash), ERYTHEMA (Redness) and FATIGUE (Fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced CONTUSION (Bruise), RASH (Rash), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain at injection (left)). On 28-Jan-2021, the patient experienced TENDERNESS (Tenderness) and ERYTHEMA (Redness). On 30-Jan-2021, the patient experienced FATIGUE (Tired). On 23-Jan-2021, CONTUSION (Bruise), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain at injection (left)) had resolved. On 27-Jan-2021, RASH (Rash) had resolved. On 01-Feb-2021, TENDERNESS (Tenderness) and ERYTHEMA (Redness) had resolved. At the time of the report, FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment details included neosporin ointment, lidocaine and recommended getting vaccine in different arm.
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: I broke out in a really bad rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (I broke out in a really bad rash) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (I broke out in a really bad rash). At the time of the report, RASH (I broke out in a really bad rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain
Clinical narrative: This spontaneous case was reported by a physician and describes the occurrence of CHILLS (Chills), FATIGUE (Fatigue), HEADACHE (Headache) and PAIN (Very very sore arm that was hard to even raise) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. Concurrent medical conditions included Cervical pain. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced CHILLS (Chills), FATIGUE (Fatigue), HEADACHE (Headache) and PAIN (Very very sore arm that was hard to even raise). On 31-Jan-2021, CHILLS (Chills), FATIGUE (Fatigue), HEADACHE (Headache) and PAIN (Very very sore arm that was hard to even raise) had resolved. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications included pain medications for chronic cervical pain management. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: adverse effects; A spontaneous report was received from a consumer concerning a male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced adverse effects.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: UNKNOWN) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced  adverse effects (not specified).  No lab data was provided.  Treatment details was unknown.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events-adverse effects was considered to be unknown.; Reporter's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heart rate, Lymphadenopathy, Nausea, Oropharyngeal pain
Clinical narrative: Throat pain; Swollen tonsils; Swollen neck lymph nodes (opposite side of the injection0; Fever; Vertigo; Headache; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo), OROPHARYNGEAL PAIN (Throat pain), TONSILLAR HYPERTROPHY (Swollen tonsils), HEADACHE (Headache) and NAUSEA (Nauseous) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced VERTIGO (Vertigo), HEADACHE (Headache), NAUSEA (Nauseous) and PYREXIA (Fever). On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Throat pain), TONSILLAR HYPERTROPHY (Swollen tonsils) and LYMPHADENOPATHY (Swollen neck lymph nodes (opposite side of the injection0). On 16-Jan-2021, NAUSEA (Nauseous) had resolved. On 18-Jan-2021, VERTIGO (Vertigo), HEADACHE (Headache) and PYREXIA (Fever) had resolved. At the time of the report, OROPHARYNGEAL PAIN (Throat pain), TONSILLAR HYPERTROPHY (Swollen tonsils) and LYMPHADENOPATHY (Swollen neck lymph nodes (opposite side of the injection0) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: increased (High) increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant drugs included no treatment drugs included   Most recent FOLLOW-UP information incorporated above includes: On 03-Feb-2021: follow up received contain no significant information
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tonsillar hypertrophy, Vertigo
Clinical narrative: Throat pain; Swollen tonsils; Swollen neck lymph nodes (opposite side of the injection0; Fever; Vertigo; Headache; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo), OROPHARYNGEAL PAIN (Throat pain), TONSILLAR HYPERTROPHY (Swollen tonsils), HEADACHE (Headache) and NAUSEA (Nauseous) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced VERTIGO (Vertigo), HEADACHE (Headache), NAUSEA (Nauseous) and PYREXIA (Fever). On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Throat pain), TONSILLAR HYPERTROPHY (Swollen tonsils) and LYMPHADENOPATHY (Swollen neck lymph nodes (opposite side of the injection0). On 16-Jan-2021, NAUSEA (Nauseous) had resolved. On 18-Jan-2021, VERTIGO (Vertigo), HEADACHE (Headache) and PYREXIA (Fever) had resolved. At the time of the report, OROPHARYNGEAL PAIN (Throat pain), TONSILLAR HYPERTROPHY (Swollen tonsils) and LYMPHADENOPATHY (Swollen neck lymph nodes (opposite side of the injection0) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: increased (High) increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant drugs included no treatment drugs included   Most recent FOLLOW-UP information incorporated above includes: On 03-Feb-2021: follow up received contain no significant information
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Eyelid irritation
Clinical narrative: Eyelids irritation; A spontaneous report was received from a 72-year-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced eyelids irritation.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 30 Jan 2021, approximately three days prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (latch number: 013L20A) for prophylaxis of COVID-19 infection.  On 01 Feb 2021, the patient experienced eyelids irritation. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.   The outcome of event eyelids irritation was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Musculoskeletal pain, Myalgia, Rash
Clinical narrative: developed a rash that looked like shingles; ache on the left side of my buttocks; Headache; Bodyaches; chills; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL PAIN (ache on the left side of my buttocks), RASH (developed a rash that looked like shingles), MYALGIA (Bodyaches), CHILLS (chills) and HEADACHE (Headache) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included MULTIVITAMIN [VITAMINS NOS] and VITAMIN B12 NOS (VITAMIN B 12 [VITAMIN B12 NOS]) for an unknown indication.    On 21-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced MYALGIA (Bodyaches) and CHILLS (chills). On 22-Jan-2021, the patient experienced HEADACHE (Headache). On 24-Jan-2021, the patient experienced MUSCULOSKELETAL PAIN (ache on the left side of my buttocks). On 29-Jan-2021, the patient experienced RASH (developed a rash that looked like shingles). At the time of the report, MUSCULOSKELETAL PAIN (ache on the left side of my buttocks), RASH (developed a rash that looked like shingles), MYALGIA (Bodyaches), CHILLS (chills) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information was provided.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeding disorder, Lip swelling, Myalgia, Nausea
Clinical narrative: pins and needles in legs; lips started to swell; throat became a little swollen; face swelling; couldn't eat for two days; nauseated; chills; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (pins and needles in legs), LIP SWELLING (lips started to swell), PHARYNGEAL SWELLING (throat became a little swollen), SWELLING FACE (face swelling) and FEEDING DISORDER (couldn't eat for two days) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Jan-2021, the patient experienced PARAESTHESIA (pins and needles in legs), LIP SWELLING (lips started to swell), PHARYNGEAL SWELLING (throat became a little swollen), SWELLING FACE (face swelling), FEEDING DISORDER (couldn't eat for two days), NAUSEA (nauseated), CHILLS (chills) and MYALGIA (muscle aches). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. On 25-Jan-2021, PARAESTHESIA (pins and needles in legs), LIP SWELLING (lips started to swell), PHARYNGEAL SWELLING (throat became a little swollen), SWELLING FACE (face swelling), FEEDING DISORDER (couldn't eat for two days), NAUSEA (nauseated), CHILLS (chills) and MYALGIA (muscle aches) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication include birth control and steroids.  Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Follow up contains Concomitant details was updated, second dose details updated.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pharyngeal swelling, Swelling face
Clinical narrative: pins and needles in legs; lips started to swell; throat became a little swollen; face swelling; couldn't eat for two days; nauseated; chills; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (pins and needles in legs), LIP SWELLING (lips started to swell), PHARYNGEAL SWELLING (throat became a little swollen), SWELLING FACE (face swelling) and FEEDING DISORDER (couldn't eat for two days) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Jan-2021, the patient experienced PARAESTHESIA (pins and needles in legs), LIP SWELLING (lips started to swell), PHARYNGEAL SWELLING (throat became a little swollen), SWELLING FACE (face swelling), FEEDING DISORDER (couldn't eat for two days), NAUSEA (nauseated), CHILLS (chills) and MYALGIA (muscle aches). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. On 25-Jan-2021, PARAESTHESIA (pins and needles in legs), LIP SWELLING (lips started to swell), PHARYNGEAL SWELLING (throat became a little swollen), SWELLING FACE (face swelling), FEEDING DISORDER (couldn't eat for two days), NAUSEA (nauseated), CHILLS (chills) and MYALGIA (muscle aches) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication include birth control and steroids.  Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Follow up contains Concomitant details was updated, second dose details updated.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Cough, Depression, Fatigue
Clinical narrative: General ill feeling; cough; Malaise; depressed; Fatigue; Joint pain; Chills; Local pain at the injection site; Wave of ill feeling in his lower throat (below the voice box); This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Wave of ill feeling in his lower throat (below the voice box)), FEELING ABNORMAL (General ill feeling), COUGH (cough), MALAISE (Malaise) and DEPRESSION (depressed) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Insomnia, GERD, Hypertension, Atrial fibrillation, Dyslipidemia and Allergic rhinitis. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for Atrial fibrillation, AMLODIPINE for Blood pressure high, FENOFIBRATE for Dyslipidemia, BISOPROLOL for Hypertension, ZOLPIDEM for Insomnia.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (Wave of ill feeling in his lower throat (below the voice box)), MALAISE (Malaise), DEPRESSION (depressed), FATIGUE (Fatigue), ARTHRALGIA (Joint pain), CHILLS (Chills) and VACCINATION SITE PAIN (Local pain at the injection site). On an unknown date, the patient experienced FEELING ABNORMAL (General ill feeling) and COUGH (cough). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, OROPHARYNGEAL PAIN (Wave of ill feeling in his lower throat (below the voice box)), FEELING ABNORMAL (General ill feeling), COUGH (cough), FATIGUE (Fatigue), ARTHRALGIA (Joint pain) and CHILLS (Chills) outcome was unknown and MALAISE (Malaise), DEPRESSION (depressed) and VACCINATION SITE PAIN (Local pain at the injection site) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: No specific follow-up information recorded.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Malaise, Oropharyngeal pain, Vaccination site pain
Clinical narrative: General ill feeling; cough; Malaise; depressed; Fatigue; Joint pain; Chills; Local pain at the injection site; Wave of ill feeling in his lower throat (below the voice box); This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Wave of ill feeling in his lower throat (below the voice box)), FEELING ABNORMAL (General ill feeling), COUGH (cough), MALAISE (Malaise) and DEPRESSION (depressed) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Insomnia, GERD, Hypertension, Atrial fibrillation, Dyslipidemia and Allergic rhinitis. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for Atrial fibrillation, AMLODIPINE for Blood pressure high, FENOFIBRATE for Dyslipidemia, BISOPROLOL for Hypertension, ZOLPIDEM for Insomnia.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (Wave of ill feeling in his lower throat (below the voice box)), MALAISE (Malaise), DEPRESSION (depressed), FATIGUE (Fatigue), ARTHRALGIA (Joint pain), CHILLS (Chills) and VACCINATION SITE PAIN (Local pain at the injection site). On an unknown date, the patient experienced FEELING ABNORMAL (General ill feeling) and COUGH (cough). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, OROPHARYNGEAL PAIN (Wave of ill feeling in his lower throat (below the voice box)), FEELING ABNORMAL (General ill feeling), COUGH (cough), FATIGUE (Fatigue), ARTHRALGIA (Joint pain) and CHILLS (Chills) outcome was unknown and MALAISE (Malaise), DEPRESSION (depressed) and VACCINATION SITE PAIN (Local pain at the injection site) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: No specific follow-up information recorded.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Nail discolouration, Skin discolouration
Clinical narrative: woke up right palm was orange; cuticles were orange too; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (woke up right palm was orange) and NAIL DISCOLOURATION (cuticles were orange too) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SKIN DISCOLOURATION (woke up right palm was orange) and NAIL DISCOLOURATION (cuticles were orange too). At the time of the report, SKIN DISCOLOURATION (woke up right palm was orange) and NAIL DISCOLOURATION (cuticles were orange too) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Rash, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Little soreness; Rash; Itching; Slight red mark that its growing; Arm swelled; Little sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Little sore arm), PAIN (Little soreness), RASH (Rash), VACCINATION SITE PRURITUS (Itching) and VACCINATION SITE ERYTHEMA (Slight red mark that its growing) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (Little sore arm). On 30-Jan-2021, the patient experienced PAIN (Little soreness), RASH (Rash), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE ERYTHEMA (Slight red mark that its growing) and VACCINATION SITE SWELLING (Arm swelled). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 23-Jan-2021, PAIN IN EXTREMITY (Little sore arm) had resolved. At the time of the report, PAIN (Little soreness), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE ERYTHEMA (Slight red mark that its growing) and VACCINATION SITE SWELLING (Arm swelled) had resolved and RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported     Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Events outcome was updated, treatment using acetaminophen was reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Little soreness; Rash; Itching; Slight red mark that its growing; Arm swelled; Little sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Little sore arm), PAIN (Little soreness), RASH (Rash), VACCINATION SITE PRURITUS (Itching) and VACCINATION SITE ERYTHEMA (Slight red mark that its growing) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (Little sore arm). On 30-Jan-2021, the patient experienced PAIN (Little soreness), RASH (Rash), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE ERYTHEMA (Slight red mark that its growing) and VACCINATION SITE SWELLING (Arm swelled). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 23-Jan-2021, PAIN IN EXTREMITY (Little sore arm) had resolved. At the time of the report, PAIN (Little soreness), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE ERYTHEMA (Slight red mark that its growing) and VACCINATION SITE SWELLING (Arm swelled) had resolved and RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported     Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Events outcome was updated, treatment using acetaminophen was reported.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site cellulitis, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: Almost looked like cellulitis; Completely swollen about the side of a baseball; Arm was hot red; Arm was really hot; It was itching; Rash; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE CELLULITIS (Almost looked like cellulitis), VACCINATION SITE SWELLING (Completely swollen about the side of a baseball), VACCINATION SITE ERYTHEMA (Arm was hot red), VACCINATION SITE WARMTH (Arm was really hot) and VACCINATION SITE PRURITUS (It was itching) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE CELLULITIS (Almost looked like cellulitis), VACCINATION SITE SWELLING (Completely swollen about the side of a baseball), VACCINATION SITE ERYTHEMA (Arm was hot red), VACCINATION SITE WARMTH (Arm was really hot), VACCINATION SITE PRURITUS (It was itching) and VACCINATION SITE RASH (Rash). At the time of the report, VACCINATION SITE CELLULITIS (Almost looked like cellulitis), VACCINATION SITE SWELLING (Completely swollen about the side of a baseball), VACCINATION SITE ERYTHEMA (Arm was hot red), VACCINATION SITE WARMTH (Arm was really hot), VACCINATION SITE PRURITUS (It was itching) and VACCINATION SITE RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were provided by reporter  No treatment were reported
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Almost looked like cellulitis; Completely swollen about the side of a baseball; Arm was hot red; Arm was really hot; It was itching; Rash; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE CELLULITIS (Almost looked like cellulitis), VACCINATION SITE SWELLING (Completely swollen about the side of a baseball), VACCINATION SITE ERYTHEMA (Arm was hot red), VACCINATION SITE WARMTH (Arm was really hot) and VACCINATION SITE PRURITUS (It was itching) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE CELLULITIS (Almost looked like cellulitis), VACCINATION SITE SWELLING (Completely swollen about the side of a baseball), VACCINATION SITE ERYTHEMA (Arm was hot red), VACCINATION SITE WARMTH (Arm was really hot), VACCINATION SITE PRURITUS (It was itching) and VACCINATION SITE RASH (Rash). At the time of the report, VACCINATION SITE CELLULITIS (Almost looked like cellulitis), VACCINATION SITE SWELLING (Completely swollen about the side of a baseball), VACCINATION SITE ERYTHEMA (Arm was hot red), VACCINATION SITE WARMTH (Arm was really hot), VACCINATION SITE PRURITUS (It was itching) and VACCINATION SITE RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were provided by reporter  No treatment were reported
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: area is a 3 inch x 5 inch patch on muscle around the injection site; njection site became itchy; injection site became warm; fever; pink at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), VACCINATION SITE ERYTHEMA (pink at injection site), VACCINATION SITE PRURITUS (njection site became itchy), VACCINATION SITE WARMTH (injection site became warm) and VACCINATION SITE RASH (area is a 3 inch x 5 inch patch on muscle around the injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Leukaemia. Concomitant products included natural hormone replacement, LEVOTHYROXINE, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), PROBIOTIC 10, sambucol elderberry gummy and super beet chew for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PYREXIA (fever) and VACCINATION SITE ERYTHEMA (pink at injection site). On 01-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (njection site became itchy) and VACCINATION SITE WARMTH (injection site became warm). On 02-Feb-2021, the patient experienced VACCINATION SITE RASH (area is a 3 inch x 5 inch patch on muscle around the injection site). At the time of the report, PYREXIA (fever), VACCINATION SITE ERYTHEMA (pink at injection site) and VACCINATION SITE WARMTH (injection site became warm) had resolved and VACCINATION SITE PRURITUS (njection site became itchy) and VACCINATION SITE RASH (area is a 3 inch x 5 inch patch on muscle around the injection site) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment: Advil
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Coronavirus test, Nasopharyngitis
Clinical narrative: like a cold; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (like a cold) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Osteoporosis and Penicillin allergy. Concomitant products included RALOXIFENE HYDROCHLORIDE (EVISTA) for Osteoporosis.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced NASOPHARYNGITIS (like a cold). At the time of the report, NASOPHARYNGITIS (like a cold) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, Coronavirus test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided by the reporter.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Cough, Dry throat, Gait inability, Migraine
Clinical narrative: Cough; Throat dry; Migraine; Nausea; Nervous tension; Unable to walk; Vomitng;  This spontaneous case was reported by a patient and describes the occurrence of DRY THROAT (2 minutes later her throat went completely dry she did not feel that she could not breathe, she was able to drink water), GAIT INABILITY (she started to walk, and even though she did not feel dizzy, she could not walk straight or "elegantly"), TENSION (the next day she was completely wired for a 24-36hr period), MIGRAINE (She took a nap and woke up with a migrane) and COUGH (cough) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.  No medical history was reported. Concomitant products included LANSOPRAZOLE and LEVOTHYROXINE for an unknown indication.  On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced DRY THROAT (2 minutes later her throat went completely dry she did not feel that she could not breathe, she was able to drink water), GAIT INABILITY (she started to walk, and even though she did not feel dizzy, she could not walk straight or "elegantly") and NAUSEA (The first 10 minutes felt mild nauseosness). On 16-Jan-2021, the patient experienced TENSION (the next day she was completely wired for a 24-36hr period). On 17-Jan-2021, the patient experienced MIGRAINE (She took a nap and woke up with a migrane) and VOMITING (Ended up vomiting). On an unknown date, the patient experienced COUGH (cough). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Sleep problem, at an unspecified dose and frequency. On 15-Jan-2021, NAUSEA (The first 10 minutes felt mild nauseosness) had resolved. On 17-Jan-2021, TENSION (the next day she was completely wired for a 24-36hr period), MIGRAINE (She took a nap and woke up with a migrane) and VOMITING (Ended up vomiting) had resolved. At the time of the report, DRY THROAT (2 minutes later her throat went completely dry she did not feel that she could not breathe, she was able to drink water) and GAIT INABILITY (she started to walk, and even though she did not feel dizzy, she could not walk straight or "elegantly") was resolving and COUGH (cough) had resolved.  DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99 (High) 99 degree Fahrenheit.     Action taken with mRNA-1273 in response to the event was not applicable.  This case was linked to MOD-2021-219219, MOD-2021-219219 (Patient Link).  Most recent FOLLOW-UP information incorporated above includes: On 12-Jun-2021: Added event, lab data and dosage information.